Introduction
Electrical stimulation to restore lost senses and modulate dysfunctional neural systems has gained increasing acceptance by clinicians [1] , [2] . The cochlear implant is the most successful neural prosthesis. Deaf individuals can understand speech even though the cochlea is stimulated only at a few locations. A deep-brain stimulator to combat Parkinsonian tremor has recently been approved by the U.S. Food and Drug Administration. Yet, restoration of the sense of vision has not been possible. It has been known since the late 1960s that blind humans can perceive electrically elicited phosphenes in response to either retinal or cortical stimulation [3] . It took until the early 1990s for the fields of microfabrication and retinal surgery to advance to the point where it made sense to begin development of an implantable prototype retinal stimulator. Since then, a retinal prosthesis to restore vision to the blind has progressed rapidly from the conceptual phase to prototype medical devices undergoing clinical trials. Figure 1 shows a conceptual drawing of a retinal prosthesis.
The retina lines the back of the vitreous cavity, a 6 cm 3 fluid-filled space in the back of the eye that is normally filled with vitreous gel (Figure 2 ). The diseases that potentially can be treated by a retinal prosthesis are outer-retinal diseases, which include age-related macular degeneration and retinitis pigmentosa. These maladies are presently incurable and afflict hundreds of thousands worldwide [4] , [5] . They primarily affect the photoreceptors of the retina, leaving the other retina layers relatively spared [6] . However, the other retinal cells are modified after photoreceptor loss [7] . The degree of modification is related to the time after photoreceptor loss. The dendritic trees of the bipolar and ganglion cells retract, and cells migrate into different layers. A thick glial seal forms between the retina and the subretinal space (where the photoreceptors used to be). In other words, after degeneration of the photoreceptors, the remaining retina also undergoes significant change.
Although the idea of replacing a lost sense of vision with an electronic device can be traced to a patent awarded to Graham Tassicker [8] , the realization of a device suitable for initial testing in humans required years of advances in vision science, retinal surgery, and microelectronics. Many more technical advances will be needed to implement a high-resolution implant. However, the research that has been accomplished to date provides strong evidence that a high-resolution device may restore significant vision. Testing of prototype low-resolution devices has demonstrated that totally blind individuals can discriminate simple objects [9] , [10] . This review will summarize the important findings to date from preclinical biological testing and clinical trials of retinal stimulation as well as briefly discuss recent technical advances. For lengthier reviews of retina implants, the reader is referred to recent publications [11] , [12] .
Other Approaches to Artificial Vision
Experimental artificial vision systems have electrically stimulated other anatomical locations in the visual system. The first experimental work towards a visual prosthesis began with electrical stimulation of the visual cortex using a grid of large surface electrodes. This has progressed to microelectrode arrays that penetrate deep into the cortex. A brief summary of the important findings in visual cortex stimulation is given below.
The seminal experiment in this field (and possibly in the field of neural prosthesis) was performed by Giles Brindley in 1968 [13] . Brindley implanted an 80-electrode device on the visual cortical surface of a 52-year-old nurse blind from bilateral severe glaucoma and retinal detachment in the left eye. Each electrode was connected by a wire to a radio receiver screwed to the outer bony surface. An oscillator coil was placed above a given receiver in order to activate the receiver via radio frequency and stimulate the cortex via the induced electrical current. With this system, the patient was able to see light points in 40 different positions of the visual field, demonstrating that at least half of the implanted electrodes were functional. This experiment showed that a chronically activated electrical stimulation device could restore some degree of vision. However, because surface electrodes were used, large stimulus currents were needed in order to produce the sensation of light, and these phosphenes were quite large.
The need for more localized phosphenes forced the development of intracortical electrodes that could penetrate into the cortex and stimulate only a small number of cells. An array of stimulating microelectrodes were inserted into the occipital cortex of patients who were being treated for excision of epileptic foci [14] . Phospenes were elicited with both surface and intracortical electrodes, but intracortical microstimulation required 10-100 times less current than surface electrodes. The same group later implanted in the visual cortex a system with 38 microelectrodes. This was done in a test subject blind from glaucoma. The electrodes were implanted for a period of four months. Despite being blind for many years, the subject was able to perceive phosphenes at a predictable and reproducible location of the visual space. It was also demonstrated that several microelectrodes used in combination could evoke the perception of patterns.
More recent work in a nonhuman primate (NHP) model has demonstrated the efficacy of cortical implants for vision [15] . A stimulating array was implanted in the visual cortex of a monkey. The monkey was trained to reach to a location in the visual field that was illuminated by a light. This area was mapped using electrical activity recorded on the electrodes. It was then demonstrated that electrical stimulation on that electrode produced the sensation of a visual percept in the same area, and the monkey was able to perform the same visual saccade task with both light and electrical stimulation.
Optic-nerve stimulation has been demonstrated in one subject [10] . A stimulator connected to a cuff electrode with four contacts was implanted in a retinitis pigmentosa (RP) patient. The cuff electrode encircled the optic nerve, which is about 1-2 mm in diameter. Since the electrodes are on the outside of a very densely packed nerve (1.2 million fibers within the nerve), focal stimulation and detailed perception are difficult to achieve. Stimulation through a single electrode sometimes produces multiple percepts throughout the visual field. However, the test subject has adopted a strategy of scanning a head-worn camera to achieve remarkable results in pattern recognition.
Sensory substitution devices have been developed that stimulate other senses to convey visual information [16] . Systems have been developed that convert visual information, captured by a camera, into auditory or tactile stimuli. One group has developed a tactile stimulator that resides on the tongue. Using a 12 × 12 grid of tongue electrodes, they have demonstrated that blind individuals can perform a simple visual task equating to 20/430 vision [17] . Test subjects identified the orientation of the letter E using a camera to scan the image and the tongue stimulator to relay the image brain. While this level of visual acuity would certainly be helpful to a completely blind individual, sensory substation devices have not gained widespread use, possibly because they occupy another sensory modality, thus trading one function for another. An electronic retinal prosthesis, in contrast, will directly activate the visual system.
Retinal Prostheses
Compared to the optic-nerve prostheses, cortical prosthesis, and sensory substitution devices, the retinal prosthesis approach has distinct advantages. The retina lines the back of the vitreous cavity, a 6-cm 3 space in the back of the eye that is normally filled with vitreous gel but is routinely replaced with saline (after removing the vitreous during retinal surgery) (Figure 1 ). This fluid-filled cavity will permit a device of significant size to be placed near the retina without disrupting other tissue. The output neurons of the retina (ganglion cells) are within 20 µm of the surface of the retina, thus an electrode placed on the surface of the retina is very near the target cells, allowing the stimulus current to be focal and within safe limits, even with small electrodes. The receptive field properties of the retina are well known, so electrical stimulation of an area of the retina produces the perception of light in a predictable location. The main disadvantage of a retinal prosthesis is the need for remaining retinal neurons, which precludes application to significant blinding diseases such as glaucoma. 
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Experimental Studies of Retinal Prosthesis
Two locations in the eye have been proposed for retinal prostheses: the epiretinal surface and the subretinal space ( Figure 2 ). An epiretinal implant will rest on the inner limiting membrane of the retina, while a subretinal implant would be inserted in the space occupied by photoreceptors in a healthy retina. Both approaches have advantages and disadvantages (see Table 1 ). Whether on the retina or under the retina, a device that is to be implanted in a human must be safe to the eye and achieve some level of effectiveness in restoring vision. Biological research studies into retinal implants have focused on these questions. The area has seen increasing activity over the past 15 years. Early work focused on electrophysiology testing in animal models of retina disease. Temporary implants in blind humans showed initial feasibility, while long-term implantation studies in animals led the way to chronic implants in humans. In the remainder of this article, the work in each of these areas will be reviewed briefly.
Safety of Implantation and Stimulation
Early safety studies have primarily assessed how well the retina tolerates the surgery required to place the device and the long-term mechanical interaction between the implant and tissue. More recent studies have looked at chronic electrical stimulation. Implant studies of epiretinal placement in research animals showed similar results. Implantation of a handmade electrode array in dog demonstrated that a relatively large device could be implanted in the eye and that a cable could traverse the eye wall without dramatically increased risk of infection [18] . No retinal detachment occurred, and only retinal pigment epithelium (RPE) changes were noted near the retinal tacks, which were used for fixation of the epiretinal implant. In another study of epiretinal implantation of a polyimide foil electrode, it was reported that nine out of ten rabbits were implanted without serious complications [19] . The implant was stable at its original fixation area, and no change in retinal architecture underneath the implant was found by light microscopy. In three cases, mild cataract formation was observed, and in one case, a total retinal detachment was found after six months of follow up. Both studies showed evidence of damage at the edge of the implant, away from the stimulating electrodes. A recent study of chronic retinal stimulation in canine demonstrated that stimulus current for 120 days did not cause noticeable changes in the retina [20] . Stimulus pulses up to 180 µA (1 ms/phase, biphasic pulses, 60 pulses per second) were applied via an epiretinal stimulator in one eye each of three blind and three sighted dogs. No inflammatory reaction, neovascularization, or hemorrhage was observed during the follow-up examinations. Stimulus levels used were of sufficient amplitude to elicit cortical evoked potentials. Histological evaluation showed no inflammatory infiltrates or changes in retina morphometry related to electrical stimulation when compared to the unstimulated control eye. Morphometric analysis revealed no consistent differences relating to electrical stimulation. In summary, this level of stimulation did not cause any damage to the retina. Subretinal implants have been done in several animal models to study the long-term effects of implantation [21] . This was concerning, since it was thought that placement of a device in the subretinal space may lead to retina detachment. This has not been shown to be the case in multiple studies in animals. Chow implanted an artificial silicon retina (ASR) in cat subretinal space for several years in cats without causing retinal detachment. There was significant degeneration to the outer nuclear layer; however, the inner retina was not damaged. Similar experiments in Yucatan minipig showed similar results [22] . However, since a subretinal implant will require extraocular components to provide power, the complete implant will have a subretinal stimulating array and supporting microelectronics for stimulus generation and telemetry. Studies into this surgical placement have shown some feasibility as a result of shorter-term electrophysiology experiments, but placement of a realistically sized device has yet to be proven.
Subretinal implantation of an ASR in rats with a model of outer-retina disease did show an increased survival of photoreceptors, but this effect was present in both rats with inactive and active implants [23] . RCS rats were implanted and showed continued decline in visual function throughout the eight weeks post implant. Histologically, the rats with implants, active or inactive, showed improved photoreceptor survival versus unoperated control and versus operated but not implanted control. The inactive implants showed the greatest survival of photoreceptors. This suggests that a chronic foreign-body reaction may result in improved overall retina health.
Efficacy of Stimulation
Numerous electrical stimulation studies have been performed in animals and the results have been reviewed elsewhere [24] , [25] . The threshold for these studies is typically determined by ganglion cell response or cortical response. Most of the work has been done in normal retina, since a light response can be used to confirm the placement of recording electrodes. However, more studies are revealing the differences between normal and diseased retina. To compare these studies, it is convenient to express the electrical stimulus in terms of coulombs rather than amperes, since current pulses (in amperes) are of variable duration and since electrical stimulation safety limits are often expressed in coulombs. The stimulus threshold in these studies ranged from 0.9-50 nC, which is in the range of other neural systems. These also suggest that the stimulus would not damage the retina by supplying too much charge [26] .
Clinical Trials of Retinal Stimulation
In parallel with the many animal studies that have been done, limited clinical trials have been performed that have demonstrated the promise and the challenges of a retinal prosthesis. These initially involved acute trials (i.e., placing a device temporarily into the eye to stimulate the retina, then removing it in less then 3 h). These experiments were done in an operating room setting. Later, after significant safety testing in animal models, limited clinical trials were begun with both epiretinal and subretinal implants.
The first acute stimulation experiments in humans stimulated the retinal surface of blind patients to investigate the basic response properties [27] . A series of acute stimulation experiments demonstrated several important results. In the initial experiments, the subjects correctly reported the position of the phosphene. A second acute study showed that subjects could perceive shapes with patterned electrical stimulation from a multielectrode array [28] . A third study involving electrical stimulation in human retina with partial loss of photoreceptors showed differences in the response properties between normal and damaged retina [29] . Since hand-held electrodes were used in these experiments, the distance between the retina and the stimulating electrodes resulted in two limitations: the possible resolution and large threshold currents, on average 600 µA for 1 ms, which was ten times greater than animal study thresholds. The second research team to do acute human experiments used a gold weight, which held a thin film electrode array on the surface of the retina [30] . This technique assured close apposition of the electrode to the retina and resulted in more consistent thresholds (compared to the earlier work), but perception still required stimulus currents in the range of 300-500 µA for 1 ms. Responses could not be elicited with stimulation through a 50-µm-diameter electrode since the safe current limit decreases with electrode size. In these studies, patterned stimulation with multielectrode arrays resulted in perceptions different from the stimulus pattern [31] . However, the percepts were reproducible for a given stimulus pattern, suggesting that image processing can solve the problem of evoking perception of specific shapes. An artificial silicon retina (ASR) has been developed to replace photoreceptor function [32] . The ASR consists of an array of thousands of microphotodiodes. It is designed to be implanted in the subretinal space and produce electrical stimulus current in response to light, similar to how photoreceptors transduce light into a neural signal. It has recently been shown that the amount of electrical current produced in response to ambient light is very low and unlikely to elicit a neural response [33] . This agrees with the results from the clinical trial of this device. In the clinical trial, the subjects do not have pixelized vision that can be attributed directly to the operation of the implant. However, the subjects do report improved vision after implantation, which appears to be indirectly related to the device.
A second clinical trial, with an epiretinal stimulator, has yielded important results that suggest a higher-resolution device may be realizable and more effective [9] , [34] . A low-resolution prototype device was implanted in three blind test subjects as part a Phase I safety study. The device has only a 4 × 4 grid of platinum electrodes (on the epiretinal surface) that are activated by a subcutaneous stimulator positioned behind the ear (the stimulator and electrodes are connected by a multiwire cable running into the eye). Figure 3 shows the electrode array of this device through a dilated pupil. An external camera worn in a eyeglass frame is used to control the stimulator via a wireless link across the skin. Using this device, subjects who can otherwise see only light or dark are able to discriminate between objects in a set and recognize motion. Also, the threshold for perception is lower than anticipated, possibly allowing denser arrays with smaller electrodes [34] . Simulations of prosthetic vision suggest that as the number of pixels is increased, performance in visual tasks will improve [35] .
Engineering Research in Retinal Prosthesis Technology
Current technology development is focused on increasing the number of stimulus channels above the state of the art. Cochlear implants have at most 32 channels. Novel technology is needed to achieve the hundreds of pixels that are predicted as the requirement for a useful visual prosthesis. Recent advances in microelectronic design, wireless communication, and microsystems represent progress towards this goal.
Microelectronics will perform several functions in a retinal prosthesis, including wireless communication between the external and implanted units and producing stimulus current in the implant. A 60-channel stimulator chip, fabricated in 1.2-µm CMOS technology, has been designed, fabricated, and tested by Liu and coworkers [36] . This same research group has also designed and tested custom microchips for telemetry [37] . Power-efficient circuits have been developed for retinal prosthesis [38] . While advances in electronic fabrication technology may provide some benefit for retinal microelectronics, the high-voltage requirements for neural stimulation will limit the use of the smallest feature size technology [11] .
A retinal stimulating array must be flexible to conform to the spherical shape of the retina. One way to achieve such a device is with a polymer substrate that can support patterned metal traces and electrodes. Two potential polymers that are being investigated are polydimethyl siloxane (PDMS) and parylene. PDMS test arrays were implanted in four canine eyes for up to six months [39] . They showed superior mechanical characteristics, conforming to the retinal curvature without damaging the retina with undue pressure. Parylene has not yet been tested intraocularly, but it has been shown to be biocompatible for other implants. A novel method for integrating a stimulating electrode with chip interconnects into a single process has recently been described [40] .
Conclusions
Biological testing in both animal models and human test subjects has provided sufficient data to inform the design of future retinal prosthesis. Strong evidence has been presented that suggests implantation and electrical stimulation of the retina is safe. Effectiveness is more difficult to define. The human eye uses over 100 million photoreceptors to form an image, so an electronic device will never replace this resolution, at least not in the near future. However, it may be possible to restore a good amount of visual function that can be augmented by other assistive devices. Considering that so many blinding diseases have no cure and result in complete blindness, a partial restoration of sight will still be a major achievement and is within reach.
